§ Same category · GLP-1 / metabolic peptides
AOD-9604 vs Tirzepatide
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
AOD-9604
0
vendors tracked
Tirzepatide
0
vendors tracked
AOD-9604
Lipolytic GH fragment
No current listings at 5mg.
Tirzepatide
Dual GLP-1/GIP agonist
No current listings at 10mg.
About AOD-9604
A modified fragment of the C-terminus of human growth hormone studied for its lipolytic effects. Originally developed as an obesity drug candidate.
About Tirzepatide
A once-weekly dual GIP and GLP-1 receptor agonist studied for type-2 diabetes and obesity. Approved clinically in many jurisdictions; research-compound form is widely distributed.